NEO
NeoGenomics Inc
NASDAQ: NEO · HEALTHCARE · DIAGNOSTICS & RESEARCH
$9.26
+3.35% today
Updated 2026-04-30
Market cap
$1.17B
P/E ratio
—
P/S ratio
1.60x
EPS (TTM)
$-0.84
Dividend yield
—
52W range
$5 – $14
Volume
2.1M
NeoGenomics Inc (NEO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-14.80%
Operating margin
-6.56%
ROE
-12.40%
ROA
-2.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $6.48M | $-130000.00 | 57.40% | 2.16% | -2.01% |
| 2007 | $11.51M | $-3.38M | 51.99% | -27.30% | -29.38% |
| 2008 | $20.02M | $-1.38M | 53.27% | -4.42% | -6.91% |
| 2009 | $29.47M | $-2.24M | 51.63% | -5.86% | -7.61% |
| 2010 | $34.37M | $-3.30M | 45.92% | -8.62% | -9.61% |
| 2011 | $43.48M | $-1.18M | 44.68% | -0.94% | -2.71% |
| 2012 | $59.87M | $65000.00 | 44.83% | 2.02% | 0.11% |
| 2013 | $66.47M | $2.03M | 47.75% | 4.78% | 3.06% |
| 2014 | $87.07M | $1.13M | 46.76% | 2.55% | 1.30% |
| 2015 | $99.80M | $-2.54M | 43.84% | -5.65% | -2.54% |
| 2016 | $244.08M | $-6.14M | 45.22% | 1.05% | -2.52% |
| 2017 | $240.25M | $-396000.00 | 42.44% | 1.21% | -0.16% |
| 2018 | $276.74M | $2.64M | 45.99% | 3.63% | 0.95% |
| 2019 | $408.83M | $8.01M | 48.15% | 3.18% | 1.96% |
| 2020 | $444.45M | $4.17M | 41.83% | -3.15% | 0.94% |
| 2021 | $484.33M | $-8.35M | 38.62% | -24.52% | -1.72% |
| 2022 | $509.73M | $-144.25M | 36.86% | -30.92% | -28.30% |
| 2023 | $591.64M | $-87.97M | 41.34% | -18.21% | -14.87% |
| 2024 | $660.57M | $-78.73M | 43.92% | -13.94% | -11.92% |
| 2025 | $727.33M | $-108.03M | 38.85% | -9.09% | -14.85% |